Patient Guide: Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 98 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06958328
Status: 🟢 Enrolling Now
Condition: Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8
Phase: PHASE3

Where You Can Participate

This study is available at 98 locations across the country.

Top locations include:
  • • Gilbert, Arizona
  • • Peoria, Arizona
  • • Phoenix, Arizona
  • • And 95 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer - Join Clinical Trial NCTNCT06958328

How to Join This Clinical Trial - NCTNCT06958328

Learn how to participate in this PHASE3 trial studying an investigational therapy for Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06958328 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 98 locations. Find a study site near you:

Clinical Research Site

Gilbert, Arizona 85297 - United States

Status: RECRUITING

Clinical Research Site

Peoria, Arizona 85381 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85027 - United States

Status: RECRUITING

Clinical Research Site

Scottsdale, Arizona 85258 - United States

Status: RECRUITING

Clinical Research Site

Surprise, Arizona 85374 - United States

Status: RECRUITING

Clinical Research Site

Tempe, Arizona 85284 - United States

Status: RECRUITING

Clinical Research Site

Jonesboro, Arkansas 72401 - United States

Status: RECRUITING

Clinical Research Site

Bakersfield, California 93301 - United States

Status: RECRUITING

Clinical Research Site

Berkeley, California 94704 - United States

Status: RECRUITING

Clinical Research Site

Cameron Park, California 95682 - United States

Status: RECRUITING

And 88 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships